Get an overview of global market outlook for machine learning in life sciences along with Identification of machine learning applications in life science sector.

The Life Science Analytics Market Report is Segmented by Product Type (Descriptive, Predictive, and Prescriptive Analytics), Component (Software Platforms and Services), Deployment Mode (On-Premise and Cloud-Based), Application (R&D, Pharmacovigilance, and More), End User (Pharma & Biotech, and More), and Geography (North America, Europe, and More). Market Forecasts are Provided in Terms of Value (USD).

Market size, estimate, forecast and CAGR for the Life Science Tools Market Size & Share Report, 2026-2033.

The Life Science Tools Market Report is Segmented by Type (Instruments, Consumables, and Services), Technology (PCR & QPCR, Sanger Sequencing, Separation Technologies, and More), Application (Proteomics Technology, Genomic Technology, and More), End User (Research Laboratories, Diagnostic Laboratories, and More), and Geography (North America, Europe, and More). The Market Forecasts are Provided in Terms of Value (USD).

Comprehensive life sciences data collection covering SAR, ADME data, toxicity values, bioactivity observations, pharmacological data, nucleic acid and protein sequences, molecular biomarkers, metabolic signaling pathways, and antibody-related proteins.

Life Science Market size is estimated to be valued at USD 108.80 Bn in 2026 and is expected to expand at a CAGR of 12.3%, reaching USD 245.07 Bn by 2033

The life sciences subject ranking uses the same trusted and rigorous performance indicators as the Times Higher Education World University Rankings 2024, but the methodology has been recalibrated to suit the individual fields. It highlights the universities that are leading across the following disciplines: agriculture and forestry, biological sciences, veterinary science, and sport science.

The Times Higher Education World University Rankings by Subject 2026 reveal the world’s top universities for life sciences, including the best universities for biology, among other subjects. The 2026 Life Sciences ranking evaluates universities across four core disciplines: veterinary science, biological sciences (including biology and biochemistry), agriculture and forestry, and sport science.

Life Science Reagents Market size was valued at USD 66.32 Billion in 2024 and is projected to reach USD 98.73 Billion by 2032, growing at a CAGR of 5.10% from 2026 to 2032.Life Science Reagents Market DriversRising Prevalence of Chronic and Infectious Diseases: The increasing incidence of chronic diseases like cancer, diabetes, and cardiovascular diseases, along with emerging infectious diseases, has driven the demand for diagnostic tests and research, boosting the use of life science reagents.Growth in Biotechnology and Pharmaceutical R&D: The expansion of biotechnology and pharmaceutical research and development, including drug discovery and development, has significantly increased the consumption of life science reagents for various assays and processes.Advancements in Genomics and Proteomics: Technological advancements in genomics, proteomics, and molecular biology, such as next-generation sequencing (NGS) and CRISPR gene editing, have accelerated the demand for specialized reagents used in research and clinical applications.Increasing Use of Reagents in Diagnostics: Life science reagents are essential in diagnostic testing, including immunoassays, PCR, and ELISA. The growing adoption of personalized medicine, companion diagnostics, and precision medicine is further fueling demand for reagents.

This chart shows annual citations to peer-reviewed articles affiliated with Database Center for Life Science, grouped by publication year.

Explore the 2025 Times Higher Education Subject Rankings for Life Sciences.

Introduction

Global AI in Life Science Market is projected to reach USD 11.38 Billion by 2033. This marks a significant increase from USD 1.87 Billion in 2023. The market is expected to grow at a CAGR of 19.8% during the forecast period from 2024 to 2033. In 2023, North America led the market, achieving over 48.6% share with a revenue of US$ 0.9 Billion.

This significant growth is driven by advancements in AI technology, particularly in healthcare, where AI enhances diagnostics, patient management, and personalized medicine. AI integration enables efficient processing of large datasets, improving health outcomes and operational efficiency. Substantial investments in AI further reinforce its promising future in life sciences applications.

Autonomous AI agents have evolved to independently execute complex tasks, mirroring real-life applications such as online shopping and academic research. These agents demonstrate vast potential in automating data collection and analysis processes, enhancing data-driven decision-making in life sciences. Continuous advancements in AI technology further highlight the transformative role of autonomous systems.

Ethical considerations remain a priority, particularly in critical sectors like healthcare and finance. Emphasis on ethical AI focuses on privacy, data governance, and fairness, ensuring responsible AI deployment. Aligning with global standards and regulatory frameworks safeguards sensitive data, promotes transparency, and maintains public trust and compliance with international data protection regulations.

In pharmaceuticals, AI is transforming drug discovery by rapidly screening and identifying potential drug candidates, significantly reducing time and costs associated with traditional methods. These technological innovations accelerate the development and market readiness of new treatments and vaccines, attracting substantial investments in AI-driven research and development.

Recent developments demonstrate this sector’s dynamic growth. In September 2023, Nuance Communications, Inc. launched Dragon Ambient eXperience (DAX) Copilot, automating clinical documentation with advanced AI. Additionally, in October 2023, IBM extended its collaboration with Amazon Web Services (AWS) to advance the adoption of generative AI technologies. These milestones highlight AI’s critical role in revolutionizing life sciences and advancing modern healthcare solutions.

Our comprehensive proprietary performance metrics of key Life Science Tools players beyond traditional revenue and ranking measures

The NASA Life Sciences Portal (NLSP) is the data platform for accessing NASA's Life Sciences Data Archive (LSDA). The LSDA is an active archive that provides information and data from 1961 (Mercury Project) through current flight and flight analog studies (International Space Station, Shuttle, bed rest studies, etc.) involving human, plant and animal subjects. Alternative contact: Jessica Keune (jessica.a.keune@nasa.gov)

Ranked dataset of the most active venture capital funds investing in United Kingdom Life Science startups, by number of investments. Updated monthly from the Shizune investor database (since 2020); includes deal counts, funding stages, round sizes, and lead/follow rates.

Life Science Tools Market size is expected to be reach USD 456 Billion by 2033, from USD 128 Billion in 2023, at a CAGR of 13.6% (2024-2033).

Ranked dataset of the most active venture capital funds investing in Australia Life Science startups, by number of investments. Updated monthly from the Shizune investor database (since 2020); includes deal counts, funding stages, round sizes, and lead/follow rates.

BCC Research Market Analyst says global market for life science tools and reagents, including COVID-19 diagnostics was valued at $59.4 billion in 2023 and expected to grow from $53.2 billion in 2024 to reach $66.5 billion by the end of 2029.

Life Science Products Market size is growing with a CAGR of 10.8% in prediction period and it crosses USD 8,830.6 Mn in 2033, from USD 4,307.4 Mn in 2026 .

Life Sciences Software Market size was valued at USD 15.35 Billion in 2023 and is projected to reach USD 43.53 Billion by 2030, growing at a CAGR of 12.9 % during the forecast period 2024-2030.

Global Life Sciences Software Market Drivers

The market drivers for the Life Sciences Software Market can be influenced by various factors. These may include:

Growing Need for Personalized Medicine: The industry is expanding due to life science software's ability to provide customized treatment regimens and analyze big datasets more easily.

A Growing Emphasis on Drug Development and Discovery: Software solutions boost market demand by speeding up research, streamlining trials, and increasing success rates.

Regulatory Compliance Requirements: Stringent regulations necessitate software solutions for data management, traceability, and reporting, boosting market adoption.

Technological Advancements: Cloud computing, AI, and machine learning innovations enable the creation of more potent and adaptable life science software.